论文信息 - 9158 A phase III study of erlotinib as maintenance therapy in NSCLC to delay progression following first-line chemotherapy (SATURN) - 字舞流文

9158 A phase III study of erlotinib as maintenance therapy in NSCLC to delay progression following first-line chemotherapy (SATURN)

G. Giaccone | F. Cappuzzo | Keunchil Park | T. Ciuleanu | G. Klingelschmitt | R. Wierzbicki | W. Hilbe | G. A. Curbera | B. Coudert | F. Custers